Workflow
宁科生物(600165) - 2015 Q3 - 季度财报
NSWRCNSWRC(SH:600165)2015-10-08 16:00

Financial Performance - Operating income decreased by 44.21% to CNY 644,416,538.52 for the first nine months compared to the same period last year[7] - Net profit attributable to shareholders was CNY -17,336,260.46, showing a significant decline from CNY -6,595,482.32 in the previous year[7] - Operating revenue decreased to ¥644,416,538.52, down 44.21% from ¥1,154,997,326.90 in the same period last year[14] - Total revenue for the third quarter was CNY 262,360,054.54, a decrease of 37.9% compared to CNY 422,594,010.02 in the same period last year[34] - The company's net profit for the first nine months was CNY 93,687,114.86, compared to CNY 86,741,881.48 in the same period last year, reflecting a year-over-year increase of 8.5%[34] - Net profit for Q3 2015 reached ¥50,574,265.10, compared to a net loss of ¥19,819,125.89 in Q3 2014[40] - Total profit for Q3 2015 was ¥50,574,265.10, significantly improving from a loss of ¥23,316,618.69 in the same period last year[39] Cash Flow - Net cash flow from operating activities increased by 252.52% to CNY 188,400,840.13 for the first nine months compared to the same period last year[7] - Operating cash flow for the period from January to September reached ¥188,400,840.13, a significant increase from ¥53,444,742.40 in the same period last year, representing a growth of approximately 252.5%[43] - Total cash inflow from operating activities was ¥1,009,361,220.16, compared to ¥1,559,811,939.48 in the previous year, indicating a decrease of about 35.2%[43] - Cash outflow from operating activities totaled ¥820,960,380.03, down from ¥1,506,367,197.08 year-on-year, a reduction of approximately 45.5%[43] - Net cash flow from investing activities decreased to -¥64,483,049.89, a decline of 190.70% compared to -¥22,181,746.47 last year[16] - The net cash flow from financing activities was ¥46,839,524.64, a turnaround from -¥42,953,705.97 in the same period last year[44] Assets and Liabilities - Total assets increased by 5.42% to CNY 2,530,852,913.63 compared to the end of the previous year[7] - The company's total liabilities reached CNY 1,599,204,918.45, compared to CNY 1,476,468,804.51 at the beginning of the year, marking an increase of about 8.3%[27] - Short-term borrowings increased due to increased bank loans and reclassification of discounted notes[12] - The company's current assets totaled CNY 1,406,022,084.08, up from CNY 1,127,230,025.26 at the beginning of the year, indicating a significant increase of about 24.7%[25] - The company's total equity amounted to CNY 931,647,995.18, slightly up from CNY 924,325,894.03, showing a marginal increase of about 0.3%[27] Shareholder Information - The number of shareholders reached 10,412 at the end of the reporting period[10] - The company reported a significant increase in minority shareholders' equity, which rose to ¥32,520,119.14, up 818.13% from ¥3,542,008.76[14] Investments and Subsidiaries - The company completed the sale of its wholly-owned subsidiary Shanghai Zhongzheng Industrial Co., Ltd. for ¥196,187,012.46, generating an investment income of ¥77,081,400.00[20] - The company plans to increase its stake in Ningxia Huahui Activated Carbon Co., Ltd. by up to 6,304 million shares, currently holding 60.21%[17] Inventory and Receivables - The company's inventory stood at CNY 407,213,890.65, up from CNY 385,969,185.42, which is an increase of about 5.3%[25] - Accounts receivable increased to CNY 376,667,720.18 from CNY 337,841,475.95, representing a growth of approximately 11.5%[25]